SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : QDEL - Quidel more quick diagnosis
QDEL 20.37-4.2%Nov 7 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Robert Busse who wrote (1562)1/25/1999 10:15:00 AM
From: Ted Gregg  Read Replies (2) of 1693
 
QUIDEL Corporation
Condensed Consolidated Statements of Operations
(In thousands, except per share data)
(unaudited)

Three months ended Nine months ended
December, 31 December, 31

1998 1997 1998 1997
Net sales $13,746 $12,447 $33,893 $32,448
Research contracts
and royalties 1,181 995 3,325 2,350
Total revenues 14,927 13,442 37,218 34,798

Gross profit
from net sales 5,776 6,256 14,824 15,632
% of sales 42.0% 50.3% 43.7% 48.2%

Research
and development 1,902 1,888 6,016 5,672
Sales and marketing 2,330 2,621 6,803 7,633
General and
administrative 1,550 978 4,306 3,368
Restructuring cost -- -- 687 --
Total operating
expenses 5,782 5,487 17,812 16,673
Other income (expense) 79 (9) 219 (41)
Pre-tax income 1,254 1,755 556 1,268
Tax provision 308 51 308 51
Net income $ 946 $1,704 $ 248 $1,217

Basic and diluted
earnings per share $.04 $.07 $.01 $.05
Shares used in
basic EPS 23,788 23,714 23,774 23,622
Shares used in
diluted EPS 23,796 23,991 23,811 23,873

Condensed Consolidated Balance Sheet Data
(In thousands)
(unaudited)

December, 31 December, 31
1998 1997

Cash and Cash Equivalents $6,012 $8,698
Working Capital 15,495 16,718
Total Assets 46,091 45,543
Stockholders' Equity 37,221 36,826
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext